Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease

NCT07793006 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT07793006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07793006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease
Lead sponsor
Indiana University
Phase
Not applicable
Overall status
Recruiting
Start date
March 17, 2025
Completion date
December 31, 2028
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, hodgkin lymphoma, kaposi sarcoma herpesvirus -associated multicentric castleman disease, lymphadenopathy, non-hodgkin lymphoma, tiny isothermal nucleic acid amplification system